Agrobacterium-Mediated Viral Replicon Expression in Plants

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current plant-based transient expression systems for recombinant protein production face challenges such as low yield, limited host range, cytotoxicity issues, and lack of biological safety, particularly when dealing with proteins like restriction enzymes and proteases, due to inefficient delivery and replication of viral vectors, which restricts their scalability and competitiveness with other expression systems.

Innovation Solution

A process using Agrobacterium-mediated delivery of viral replicons with specific genetic modifications to enhance biological safety and efficiency, involving defective Agrobacterium strains that require complementing factors for transfection, and incorporating function-conservative differences in RNA replicon sequences to improve replicon formation and expression synchronization across plant tissues.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If viral vectors are used for transient expression to achieve high yield, then protein expression level increases up to 80% of TSP, but biological safety decreases due to risk of transformation of non-target organisms

Engineering Contradiction:
Improveprotein expression levelVSAvoidbiological safety
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The viral vector system is divided into two separate Agrobacterium strains: one carrying the viral replicon (RNA genome) and another carrying the sequence of interest. This segmentation prevents the complete viral vector from being present in a single bacterium, reducing the risk of transformation while maintaining high expression capability through complementation in the plant cell.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The plant cell acts as an intermediary that receives and combines components from both Agrobacterium strains. The plant provides the environment for RNA replicon formation and subsequent expression of the sequence of interest, mediating between the two bacterial vectors and enabling high-yield production without direct bacterial transformation risk.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If standard expression cassettes with constitutive promoters are used for agro-infiltration, then ease of operation is maintained, but productivity is limited and cannot reach biological yield limits

Engineering Contradiction:
Improveagro-infiltration simplicityVSAvoidprotein yield
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The system transitions from static constitutive promoter expression to dynamic viral replication-driven expression. The RNA replicon enables rapid, high-level expression that dynamically adapts to cellular conditions, achieving up to 80% of total soluble protein while maintaining operational simplicity through agro-infiltration delivery.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The expression system changes from conventional transcriptional control to viral replication-based control, fundamentally altering the expression parameters. This enables protein yield to reach biological limits while preserving the ease of agro-infiltration application through the use of viral vectors delivered by Agrobacterium.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If infectious RNA viral vectors are used for delivery, then high expression levels are achieved, but reliability decreases due to loss of heterologous inserts during replication cycles

Engineering Contradiction:
Improveexpression levelVSAvoidinsert stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The sequence of interest is pre-assembled into a complementary DNA (cDNA) form within the viral replicon structure before delivery. This preliminary configuration protects the genetic information during Agrobacterium delivery and subsequent RNA replication, preventing loss of heterologous inserts while maintaining high expression capability.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system uses cDNA as a stable template that is transcribed into RNA for expression. This copying mechanism ensures the heterologous insert is accurately replicated from the stable DNA form to the functional RNA form, maintaining reliability while enabling high-level protein production through viral replication mechanisms.

Inventive Principle:
Principle #26Copying

4Productivity

If Agrobacterium strains with full transfection capability are used, then productivity is maximized, but biological safety worsens due to inability to confine expression to target plants

Engineering Contradiction:
Improvetransfection efficiencyVSAvoidnon-target organism transformation
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The transfection capability is segmented between two Agrobacterium strains, each carrying only part of the complete viral vector system. One strain carries the replicon while the other carries the sequence of interest, preventing either single strain from causing complete transformation while maintaining high productivity through their combined action in the plant.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Each Agrobacterium strain is engineered with specific, localized functions: one is optimized for replicon delivery while the other is optimized for sequence delivery. This local quality differentiation ensures that neither strain alone can transform non-target organisms completely, while together they achieve high transfection efficiency in target plants where both components are present.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables high-yield, large-scale, biologically safe production of recombinant proteins by ensuring synchronized expression in multiple plant cells and tissues, reducing the risk of non-target organism transformation, and increasing the frequency of RNA replicon formation, thus making the system competitive with other expression systems.

Implementation Method 1

introducing a heterologous DNA sequence into a plant cell by transfection with an Agrobacterium strain, wherein the heterologous DNA sequence has a sequence portion encoding a replicon

Methodology Applied
Scientific EffectT-DNA transfer:

Implementation Method 2

transient expression of the sequence of interest in the plant or in plant tissues, thereby producing the protein of interest

Methodology Applied
Scientific EffectTranscription and translation:

Data Source

PatentUS8093458B2Biologically safe transient protein expression in plants
Publication Date: 2012.01.10 ICON GENETICS
  • US8093458B2 patent drawing
  • US8093458B2 patent drawing
  • US8093458B2 patent drawing

AI summary

A process of producing a protein of interest by expression of said protein of interest from a sequence of interest in a plant or in plant leaves, comprising: (a) transfecting said plant or said plant leaves by infiltrating said plant or said plant leaves with an Agrobacterium strain in the presence of a complementing factor, said Agrobacterium strain containing in T-DNA a heterologous DNA sequence having a sequence portion encoding a replicon, wherein said sequence encoding a replicon contains sequences necessary for replicon function of said replicon, said sequences being derived from a plant virus, and said sequence of interest to be expressed from said replicon, (b) optionally isolating said protein of interest from said plant or said plant leaves infiltrated in step (a), wherein said Agrobacterium strain is provided with a first genetic modification rendering said Agrobacterium strain defective for transfecting organisms with said T-DNA in the absence of said complementing factor.